8-KOther Events

AGILENT TECHNOLOGIES, INC. 8-K Report (Aug 15, 2001)

Filed August 15, 2001For Securities:A

Summary

Agilent Technologies, Inc. announced the completion of the sale of its Healthcare Solutions Group to Koninklijke Philips Electronics N.V. on August 1, 2001. This significant transaction is expected to generate total cash proceeds of approximately $1.7 billion, with $1.6 billion received at closing. This divestiture represents a strategic move by Agilent to streamline its operations and focus on its core businesses. Investors should note that the sale of this segment could impact Agilent's future revenue and earnings, as the Healthcare Solutions Group was a notable part of its business. The substantial cash inflow from this sale provides Agilent with significant financial flexibility, potentially for reinvestment in growth areas, debt reduction, or shareholder returns. The full financial implications and pro forma information are expected to be detailed in the accompanying exhibits.

Key Highlights

  • 1Agilent Technologies, Inc. has completed the sale of its Healthcare Solutions Group.
  • 2The buyer is Koninklijke Philips Electronics N.V.
  • 3The transaction is expected to yield approximately $1.7 billion in total cash proceeds.
  • 4$1.6 billion of the proceeds were received on August 1, 2001.
  • 5The sale aligns with Agilent's strategic focus on core business areas.
  • 6An amendment and supplemental agreement to the asset purchase agreement was dated August 1, 2001.
  • 7A press release announcing the completion of the sale is attached as an exhibit.

Frequently Asked Questions

Agilent Technologies, Inc. sold its Healthcare Solutions Group to Koninklijke Philips Electronics N.V.

The total expected cash proceeds from the sale are approximately $1.7 billion. Of this amount, $1.6 billion was received on August 1, 2001.

This sale represents a significant divestiture for Agilent, allowing the company to focus more strategically on its core business operations. The substantial cash infusion also provides financial flexibility.

More detailed information, including pro forma financial information, can be found in Annex A following the signature page and as referenced in the exhibits section of the Form 8-K filing.